Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)
Clinical trial NCT04127019 · COMPLETED
Trial details
- NCT number
- NCT04127019
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2017-06-01
- Enrollment
- 2079
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.